Related Experiment Video
Updated: Jul 10, 2026
06:12
Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis
Published on: January 11, 2014
Axonal degeneration in motor neuron disease
Lindsey R Fischer1, Jonathan D Glass
1Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Neuro-Degenerative Diseases
|October 16, 2007
Summary
Early axonal degeneration occurs in amyotrophic lateral sclerosis (ALS) before motor neuron death. Preventing this axonal damage, possibly via antioxidants, is a key therapeutic target for ALS.
Area of Science:
- Neuroscience
- Neurology
- Motor Neuron Disease Research
Background:
- Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron degeneration.
- Emerging evidence indicates distal axonal degeneration precedes symptom onset and motor neuron death in ALS.
- Axons may undergo degeneration through mechanisms independent of parent cell body death.
Purpose of the Study:
- To review evidence for early axonal degeneration in amyotrophic lateral sclerosis (ALS).
- To discuss potential mechanisms driving axonal degeneration in ALS, focusing on oxidative stress.
- To highlight axonal degeneration as a critical therapeutic target in motor neuron disease.
Main Methods:
- Review of existing literature and animal models of ALS.
- Analysis of studies investigating motor neuron protection versus axonal protection in ALS models.
- Discussion of pathogenetic mechanisms, including oxidative stress, implicated in axonal degeneration.
Main Results:
- Axonal degeneration is an early event in ALS pathogenesis, occurring independently of motor neuron death.
- Protection of motor neurons alone has limited efficacy, suggesting a need for axonal-specific therapies.
- Oxidative stress is a plausible mechanism contributing to early axonal damage in ALS.
Conclusions:
- Axonal degeneration may be a primary driver in motor neuron disease pathogenesis.
- Therapeutic strategies aimed at preventing axonal degeneration are crucial for treating ALS.
- Targeting mechanisms like oxidative stress could offer novel treatment avenues for ALS.
Related Concept Videos
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.